Appetite and satiety
Many patients experience less hunger, greater fullness with smaller amounts of food, and a reduced drive to continue eating.
GLP-1 therapy and medical weight loss
Weight is influenced by complex biological and metabolic processes, which can make meaningful and sustained weight loss difficult to achieve through lifestyle changes alone.
At MPLC, we take a comprehensive approach to medical weight management. GLP-1-based medications may be an effective treatment option for appropriately selected patients, used alongside nutrition, physical activity, and other strategies designed to improve health and support long-term success.
Understanding GLP-1 therapy
For some patients, lifestyle changes alone may not produce the weight loss or metabolic improvement needed to meaningfully reduce health risk. GLP-1-based medications have become an important treatment option for obesity and weight-related health conditions.
Semaglutide activates GLP-1 receptors, while tirzepatide acts on both GLP-1 and GIP receptors. These medications work with pathways involved in blood-sugar regulation, appetite, food intake, and the body’s response to eating.
The goal is not simply to lose weight. It is to improve health while preserving the things that matter—especially muscle, strength, and function.
How the medications work
Many patients experience less hunger, greater fullness with smaller amounts of food, and a reduced drive to continue eating.
These therapies stimulate insulin when blood glucose is elevated, helping the body respond after eating.
Reduced glucagon signaling when glucose is elevated contributes to improved blood-glucose regulation.
Slower movement of food from the stomach can contribute to fullness and affects how quickly nutrients enter circulation.
What kind of change is possible
In the 72-week SURMOUNT-1 trial, adults receiving the highest tirzepatide dose experienced average reductions of approximately 21% in the primary treatment-regimen analysis and 22.5% in an efficacy analysis estimating outcomes while participants remained on treatment.
Those are clinical-trial averages, not a prediction of how much weight you will lose.
Could treatment be appropriate for me
GLP-1-based therapy may be considered for adults who meet appropriate medical criteria and for whom medication is expected to provide meaningful benefit. Indications and eligibility vary by medication.
Eligibility is only the beginning. Your health, risks, treatment goals, contraindications, current medications, preferences, access, and cost all belong in the decision.
The question is not simply whether you qualify for a prescription. It is whether treatment is appropriate for your health and your goals.
Before starting treatment
Your evaluation should establish more than your current weight.
When weight changed, what you have tried, what has or has not worked, and patterns of regain.
Conditions and treatments that influence weight, medication selection, or safety.
Blood pressure, glucose regulation, cholesterol, and connected risks.
Testing selected around your history, symptoms, medications, risks, previous results, and goals.
A baseline for body fat, visceral fat, skeletal muscle, and lean-mass distribution.
The circumstances that shape treatment and what improved health and function mean to you.
What you preserve matters
Weight loss can include lean tissue as well as body fat. Muscle plays an important role in strength, physical function, metabolic health, and independence as we age. That is why preserving lean mass deserves deliberate attention during substantial weight loss.
Your initial InBody 580 analysis establishes a body-composition baseline. Repeat analysis helps us follow changes in body fat and skeletal muscle as weight decreases.
The scale tells us how much you weigh. Body composition helps us understand what you are actually losing.
Explore Advanced Body Composition →Strength training is part of treatment
Regular resistance training is one of the most important tools for preserving muscle mass and strength during weight loss. Adequate protein and appropriate nutrition provide additional support, while cardiovascular exercise, daily movement, sleep, and recovery contribute to overall fitness, metabolic health, and long-term progress.
Medication can help make weight loss possible. Nutrition and exercise help determine the kind of weight you lose—and the health you build along the way.
What to expect
GLP-1-based medications are generally started at a lower dose and increased gradually. The goal is not to reach the highest dose as quickly as possible. Treatment should be adjusted based on your response, tolerability, and health goals.
As treatment takes effect, you may notice less hunger, feel satisfied with smaller portions, or remain full longer after eating. These changes can make it easier to reduce overall calorie intake, while making adequate protein and the quality of your nutrition increasingly important.
Weight loss happens over time—and not always at the same pace. Some periods may bring more noticeable change, while others may be slower or include plateaus. Rather than focusing on a specific amount of weight loss each week, we follow your overall trajectory and adjust treatment based on your response.
Successful treatment is not defined by reaching a particular dose. It is defined by how your health responds.
Side effects, risks, and monitoring
Nausea, vomiting, diarrhea, constipation, abdominal discomfort, reflux, or reduced appetite may occur, particularly after starting or increasing a dose.
Pancreatitis, gallbladder disease, dehydration and kidney injury, severe gastrointestinal symptoms, and medication interactions require appropriate attention.
Medication-specific warnings—including thyroid C-cell tumor warnings for semaglutide and tirzepatide—must be reviewed against your history.
We follow weight trends, appetite, tolerance, side effects, body composition, nutrition, activity, vital signs, and relevant health markers.
Long-term care
Losing weight and maintaining weight are different phases. Reaching a desired weight does not automatically mean treatment should stop. We reassess your body composition, muscle and strength, appetite, nutrition, exercise, metabolic and cardiovascular health, treatment tolerance, preferences, and long-term goals.
Weight regain can occur after medication is discontinued, so these therapies are generally considered long-term when they remain effective, appropriate, and well tolerated. At MPLC, duration is individualized.
Starting treatment does not mean continuing automatically. It means continuing to ask whether it remains the right treatment for you.
If GLP-1 therapy is not right for you
GLP-1-based therapy isn’t appropriate for everyone. Your medical history, treatment response, potential side effects, medication access, cost, and personal preferences all help determine which approach makes sense for you.
When GLP-1 therapy isn’t appropriate or isn’t providing the desired benefit, other evidence-based weight-management medications may be considered when clinically appropriate.
Nutrition, resistance training, physical activity, sleep, and other health factors remain important regardless of whether medication is part of the plan.
Your next step
Begin with a comprehensive Executive Health Consultation designed to understand where you are today and determine what deserves attention.